These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33616045)

  • 1. Effects of Recommendations for Diabetes Management at Hospital Discharge on Long-Term Diabetes Control.
    Shacham EC; Nitzan R; Schwartz N; Ishay A
    Endocr Pract; 2021 Feb; 27(2):118-123. PubMed ID: 33616045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes.
    Umpierrez GE; Reyes D; Smiley D; Hermayer K; Khan A; Olson DE; Pasquel F; Jacobs S; Newton C; Peng L; Fonseca V
    Diabetes Care; 2014 Nov; 37(11):2934-9. PubMed ID: 25168125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.
    Pasquel FJ; Urrutia MA; Cardona S; Coronado KWZ; Albury B; Perez-Guzman MC; Galindo RJ; Chaudhuri A; Iacobellis G; Palacios J; Farias JM; Gomez P; Anzola I; Vellanki P; Fayfman M; Davis GM; Migdal AL; Peng L; Umpierrez GE
    Diabetes Obes Metab; 2021 Jun; 23(6):1351-1360. PubMed ID: 33591621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Diabetes Medication Intensifications in Older Adults Discharged From US Veterans Health Administration Hospitals.
    Anderson TS; Lee S; Jing B; Fung K; Ngo S; Silvestrini M; Steinman MA
    JAMA Netw Open; 2020 Mar; 3(3):e201511. PubMed ID: 32207832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.
    Wexler DJ; Beauharnais CC; Regan S; Nathan DM; Cagliero E; Larkin ME
    Diabetes Res Clin Pract; 2012 Nov; 98(2):249-56. PubMed ID: 23036785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Requirements in Patients With Type 2 Diabetes Undergoing Bariatric Surgery in the Inpatient Setting and Upon Discharge: A Single-Center Retrospective Analysis of Insulin Management Strategies.
    Wirunsawanya K; Chittimoju S; Fantasia KL; Modzelewski KL; Steenkamp D; Alexanian SM
    Endocr Pract; 2021 Jun; 27(6):538-544. PubMed ID: 34016530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.
    Heller S; Koenen C; Bode B
    Clin Ther; 2009 Oct; 31(10):2086-97. PubMed ID: 19922879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes.
    Hollander P; Cooper J; Bregnhøj J; Pedersen CB
    Clin Ther; 2008 Nov; 30(11):1976-87. PubMed ID: 19108786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial.
    Miser WF; Arakaki R; Jiang H; Scism-Bacon J; Anderson PW; Fahrbach JL
    Clin Ther; 2010 May; 32(5):896-908. PubMed ID: 20685497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano D; Sieradzki J; Stefanski A; Gentilella R
    Curr Med Res Opin; 2016 Aug; 32(8):1425-34. PubMed ID: 27126277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readmission Outcomes of Sliding Scale Insulin Compared to Basal-Bolus Insulin Prescribed at Discharge in an Insulin-Naive Patient Population.
    Carter P; Eshelbrenner T; Kirk L; Fisk M; Rodrigues C
    J Pharm Pract; 2021 Oct; 34(5):780-785. PubMed ID: 32356506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use and efficacy of biphasic insulin lispro 50/50 in people with insulin treated diabetes - a nationwide evaluation of clinical practice.
    Mungreiphy NK; Mamza J; Lakhdar AF; Bannister M; Elliott J; Idris I
    Curr Med Res Opin; 2015 Mar; 31(3):493-501. PubMed ID: 25597325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.
    Gianchandani RY; Pasquel FJ; Rubin DJ; Dungan KM; Vellanki P; Wang H; Anzola I; Gomez P; Hodish I; Lathkar-Pradhan S; Iyengar J; Umpierrez GE
    Endocr Pract; 2018 Jun; 24(6):556-564. PubMed ID: 29949432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.
    Buse JB; Rodbard HW; Trescoli Serrano C; Luo J; Ivanyi T; Bue-Valleskey J; Hartman ML; Carey MA; Chang AM;
    Diabetes Care; 2016 Jan; 39(1):92-100. PubMed ID: 26577417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic control with a basal-bolus insulin protocol in hospitalized diabetic patients treated with glucocorticoids: a retrospective cohort study.
    Chertok Shacham E; Kfir H; Schwartz N; Ishay A
    BMC Endocr Disord; 2018 Oct; 18(1):75. PubMed ID: 30373567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-life glycemic control in patients with type 2 diabetes treated with insulin therapy: A prospective, longitudinal cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 9]).
    Fujita N; Yamamoto Y; Hayashino Y; Kuwata H; Okamura S; Iburi T; Furuya M; Kitatani M; Yamazaki S; Ishii H; Tsujii S; Inagaki N; Fukuhara S;
    J Diabetes Investig; 2018 Mar; 9(2):294-302. PubMed ID: 28494126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and postprandial plasma glucose contribution to glycated haemoglobin and time in range in people with type 2 diabetes on basal and bolus insulin therapy: Results from a pooled analysis of insulin lispro clinical trials.
    Liao B; Chen Y; Chigutsa F; Piras de Oliveira C
    Diabetes Obes Metab; 2021 Jul; 23(7):1571-1579. PubMed ID: 33687790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus.
    Griffith ML; Boord JB; Eden SK; Matheny ME
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2019-26. PubMed ID: 22466346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.